Crestor was FDA approved in August 2003 as a cholesterol-lowering drug. Their marketing campaign touted that their drug could lower the "bad" cholesterol while raising "good" cholesterol in the blood. On Crestor labeling, there are warnings about the potential for muscle and kidney problems. It was not even a year after FDA approval when concerned citizen groups urged the FDA to remove Crestor from the market. Crestor's pre-approval clinical trials revealed signs of it being more dangerous than Baycol, which did not indicate life-threatening instances of rhabdomyolysis. In addition, there was a lack of evidence showing that Crestor actually reduced the risk of heart attacks and strokes, as well as lowering cholesterol levels.
- Comment:
- Email Page:
- RSS Discussion:
-
|
|
|
Document Center |
Affordable & Professional
Select a document type from the list below. Most documents are prepared within just 48 hours.